Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
August 2004
2004:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2005 | 2006 | 2007 | 2008
News | News in brief | News Features
News
Universities unnerved by revised rules for sharing NIH research
Memo to US researchers: read the small print carefully before filing your next grant application to the National Institutes of Health.
Nature (26 August 2004)
| Full Text |
Director's salary makes chemists see red
The size of the pay package awarded to a former executive director of the American Chemical Society, which was nearly $768,000 in 2002, has led to protests from members.
Nature (26 August 2004)
| Full Text |
Biologists fear cloning hype will undermine stem-cell research
A dose of reality needs to be injected into the excitement surrounding therapeutic cloning, senior stem-cell biologists have warned.
Nature (19 August 2004)
| Full Text |
Firm sets sights on gene silencing to protect vision
A much-hyped technology known as RNA interference (RNAi) has moved a step closer to the clinic.
Nature (19 August 2004)
| Full Text |
Fears grow as blood stocks pass on prions undetected
New infections of variant Creutzfeldt–Jakob disease could continue unchecked unless a sensitive screen for blood donors can be devised, researchers have warned.
Nature (12 August 2004)
| Full Text |
Slipshod approvals taint Japanese animal studies
Animal-welfare campaigners have revealed irregularities in the way that animal experiments are approved in Japan.
Nature (12 August 2004)
| Full Text |
Doctors seek lost data on Alzheimer's vaccine
Data on the first experimental vaccine for Alzheimer's disease are being lost because the patients who were immunized are no longer being monitored.
Nature (12 August 2004)
| Full Text |
Petition fails to reverse massive price rise for AIDS drug
The US National Institutes of Health (NIH) has declined to impose a price cut on a key AIDS medicine.
Nature (12 August 2004)
| Full Text |
Nobel laureates spearhead effort to put Kerry in the White House
Researchers hit the campaign trail for the US presidential election.
Nature (5 August 2004)
| Full Text |
From DNA to consciousness – Crick's legacy
Francis Crick passes away at the age of 88.
Nature (5 August 2004)
| Full Text |
'Militant' animal activists trigger British law change
UK makes it illegal to gather outside homes or harass lab employees.
Nature (5 August 2004)
| Full Text |
Biotech funding deal judged to be 'a mistake' for Berkeley
Universities should avoid large-scale partnerships with industry, says report.
Nature (5 August 2004)
| Full Text |
Court ruling upsets hopes for career reforms
Scheme for young German researchers ruled unconstitutional.
Nature (5 August 2004)
| Full Text |
Research with premature infant livers touches a nerve
Most stem cell researchers are accustomed to their work being greeted with controversy. But Lola Reid's work is so contentious even those in the field call her a scientific maverick.
Nature Medicine (August 2004)
| Full Text |
London calling for British medical research institute
After months of deliberation, a task force set up to consider the future of the National Institute for Medical Research (NIMR)– one of Britain's leading centres for basic medical research – has recommended that the institute be moved from Mill Hill, on the outskirts of London, to a single site in central London.
Nature Medicine (August 2004)
| Full Text |
Disputed expenses at heart of Moncada's Spanish spat
A bitter confrontation between Spain's health ministry and noted researcher Salvador Moncada has left the management of the Spanish National Cardiovascular Center (CNIC) in limbo. The bone of contention: €13,352 that Moncada allegedly spent on travel expenses.
Nature Medicine (August 2004)
| Full
Text |
Japan sets rules for stem cell research
In an attempt to spur stem cell research and regenerative medicine, the Japanese government is getting its bioethical ducks in a row. But lingering resistance to the controversial fields will probably set limits on the speed and scope of the research.
Nature Medicine (August 2004)
| Full
Text |
Experts call for smarter approach to targeted therapies
The current generation of rational cancer drugs promises to usher in a new era by targeting distinct genetic features of tumors. But the paradigm shift in treatment needs to be accompanied by a corresponding boost in diagnostics, experts say.
Nature Medicine (August 2004)
| Full
Text |
IPO plans sour on both sides of the pond
Biotech companies had to lower their pricing before floating on public markets.
Nature Biotechnology (August 2004)
| Full
Text |
Patent drop reveals pressures on industry
Completion of the Human Genome Project and pressure for clearer applications have cut the number of US biotech patents.
Nature Biotechnology (August 2004)
| Full
Text |
Japanese firms broaden investment focus to early biotech
Young biotech companies may turn towards Japan to fund their research.
Nature Biotechnology (August 2004)
| Full
Text |
India aims to become the main bioinformatics hub
India is to combine its strength in biotechnology and IT to attract outsourcing contracts in bioinformatics.
Nature Biotechnology (August 2004)
| Full
Text |
News in brief
Monkey shortage causes delays for medical researchers |
Biotech firms settle up over HapMap contract spat |
Cash injection helps China line up HIV drugs |
More avian flu deaths confirmed in Vietnam |
Economist named as European science boss |
NIH told to get tough on outside interests |
Indian company seeks US approval for generic AIDS drugs | Korean science set for government promotion | Gene-therapy pioneer charged with child abuse |
EPA pumps cash into heart disease study |
Norwegian bids to broaden scope of science prizes |
Elsevier under fire for publishing decision |
NIH to tighten conflict-of-interest rules |
Estrogen replacement linked to dementia |
UK amends tissue bill |
Pacific population study |
Latin America initiative |
Counter-activism law in the UK | US biogenerics debated | Clinical trials confusion | FDA external scrutiny | Japan boosts cloning| EPO Oncomouse ruling| EC funds protease research
News Features
Neuroscience: While you were sleeping
Ever woken up with the answer to a problem that had seemed insoluble the night before, or able to perform a task that had previously taxed your skills? We may soon know why.
Nature (26 August 2004)
| Full Text |
Redesigner drugs
Drug development is a risky business, and the final product can have serious, sometimes deadly flaws. But by focusing on fixing those flaws, companies are catapulting themselves to profitability.
Nature Biotechnology (August 2004)
| Full Text |
|
